GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. Stock Forecast & Price Prediction

Live GE HealthCare Technologies Inc. Stock (GEHC) Price
$81.24

20

Ratings

  • Buy 13
  • Hold 6
  • Sell 1
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$81.24

P/E Ratio

23.06

Volume Traded Today

$3.2M

Dividend

$0.03

52 Week High/low

94.55/69.09

GE HealthCare Technologies Inc. Market Cap

$38.46B

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $GEHC ๐Ÿ›‘

Before you buy GEHC you'll want to see this list of ten stocks that have huge potential. Want to see if GEHC made the cut? Enter your email below

GEHC Summary

The GE HealthCare Technologies Inc. (GEHC) share price is expected to increase by 19.36% over the next year. This is based on calculating the average 12-month share price estimate provided by 20 stock analysts who have covered GEHC. Price targets range from $74 at the low end to $110 at the high end. The current analyst consensus for GEHC is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

GEHC Analyst Ratings

GEHC is a stock in Healthcare which has been forecasted to be worth $96.96632 as an average. On the higher end, the forecast price is $110 USD by David Toung from Argus Research and on the lower end GEHC is forecasted to be $74 by Patrick Wood from Morgan Stanley.

GEHC stock forecast by analyst

These are the latest 20 analyst ratings of GEHC.

Analyst/Firm

Rating

Price Target

Change

Date

Larry Biegelsen
Wells Fargo

Overweight

$96

Maintains

Oct 31, 2024
Vijay Kumar
Evercore ISI Group

Outperform

$102

Maintains

Oct 1, 2024
Rick Wise
Stifel

Buy

$102

Maintains

Sep 30, 2024
Graham Doyle
UBS

Sell

$74

Downgrade

Sep 26, 2024
Ryan Zimmerman
BTIG

Buy

$100

Upgrade

Sep 18, 2024
Robbie Marcus
JP Morgan

Neutral

$90

Initiates

Sep 9, 2024
Rick Wise
Stifel

Buy

$100

Initiates

Aug 6, 2024
David Roman
Goldman Sachs

Neutral

$87

Initiates

May 30, 2024
Anthony Petrone
Mizuho

Buy

$105

Maintains

May 1, 2024
Craig Bijou
B of A Securities

Neutral

$86

Maintains

May 1, 2024
Anthony Petrone
Mizuho

Buy

$110

Maintains

Apr 11, 2024
Vijay Kumar
Evercore ISI Group

Outperform

$100

Maintains

Apr 4, 2024
Joanne Wuensch
Citigroup

Buy

$103

Maintains

Apr 3, 2024
David Toung
Argus Research

Buy

$110

Maintains

Apr 1, 2024
Sezgi Oezener
HSBC

Buy

$100

Initiates

Feb 15, 2024
Graham Doyle
UBS

Neutral

$88

Upgrade

Feb 12, 2024
Patrick Wood
Morgan Stanley

Equal-Weight

$86

Maintains

Feb 12, 2024
Anthony Petrone
Mizuho

Buy

$96

Maintains

Feb 7, 2024
Patrick Wood
Morgan Stanley

Equal-Weight

$74

Maintains

Dec 4, 2023
Matthew Taylor
Jefferies

Hold

$80

Initiates

Nov 30, 2023

GEHC Company Information

What They Do: Develops medical imaging and diagnostic solutions.

Business Model: The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics, generating revenue by providing a wide range of medical devices, digital solutions, and diagnostic agents. It serves healthcare providers by offering products for patient diagnosis, treatment, and monitoring, while also collaborating on AI initiatives to enhance its offerings.

Other Information: Founded in 2022 and headquartered in Chicago, Illinois, the company has a broad international presence, with operations in the United States, Canada, and beyond. The rebranding from GE Healthcare Holding LLC to GE HealthCare Technologies Inc. reflects its focus on advanced healthcare technologies and solutions.
GEHC
GE HealthCare Technologies Inc. (GEHC)

When did it IPO

2023

Staff Count

51,000

Country

United States

Sector/Industry

Healthcare/Health Information Services

CEO

Mr. Peter J. Arduini

Market Cap

$38.46B

GE HealthCare Technologies Inc. (GEHC) Financial Data

In 2023, GEHC generated $19.55B in revenue, which was a increase of 6.60% from the previous year. This can be seen as a signal that GEHC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$17.16B

Revenue From 2021

$17.59B

2.45 %
From Previous Year

Revenue From 2022

$18.34B

4.30 %
From Previous Year

Revenue From 2023

$19.55B

6.60 %
From Previous Year
  • Revenue TTM $19.56B
  • Operating Margin TTM 16.1%
  • Gross profit TTM $7.92B
  • Return on assets TTM 5.6%
  • Return on equity TTM 21.9%
  • Profit Margin 8.6%
  • Book Value Per Share 18.21%
  • Market capitalisation $38.46B
  • Revenue for 2021 $17.59B
  • Revenue for 2022 $18.34B
  • Revenue for 2023 $19.55B
  • EPS this year (TTM) $3.65

GE HealthCare Technologies Inc. (GEHC) Latest News

News Image

Thu, 05 Dec 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - GE HealthCare's Aurora will broaden CT procedure options, while Clarify DL will improve SPECT image quality, potentially enhancing their product offerings and market position.

Why It Matters - GE HealthCare's advancements in CT procedures and SPECT image quality may boost demand for its products, potentially increasing revenue and improving market position, influencing investor sentiment positively.

News Image

Thu, 05 Dec 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - GE HealthCare launched three advanced deep learning imaging solutions at RSNA 2024, aimed at enhancing operational efficiency in radiology and addressing clinician burnout.

Why It Matters - GE HealthCare's new advanced imaging solutions could enhance operational efficiency and reduce clinician burnout, potentially boosting sales and market share, positively impacting stock performance.

News Image

Fri, 06 Dec 2024

Sentiment - POSITIVE

Source - Seeking Alpha

Summary - GE HealthCare Technologies is rated a buy, citing strong growth prospects, a healthy backlog, and new innovations like Flyrcado. EBIT margins target high teens to 20% through optimization and pricing strategies.

Why It Matters - GE HealthCare's strong growth prospects, healthy backlog, and innovative products position it well for future profitability, making it an attractive investment compared to peers.

News Image

Mon, 02 Dec 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - GE HealthCare has launched the Sonic DL for 3D, designed to reduce scan times and enhance image quality for most MR scans, potentially improving operational efficiency in healthcare settings.

Why It Matters - GE HealthCare's Sonic DL technology could enhance operational efficiency and attract more healthcare clients, potentially boosting revenue and market share, impacting stock performance positively.

News Image

Wed, 04 Dec 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - GE HealthCare has submitted its CleaRecon DL technology to the FDA, aimed at enhancing Cone Beam Computed Tomography (CBCT) imaging.

Why It Matters - The FDA submission for CleaRecon DL signals potential advancements in imaging technology, which could enhance GE HealthCare's competitive edge and revenue growth in the healthcare sector.

News Image

Tue, 03 Dec 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - GE HealthCare submitted a 510(k) application to the FDA for CleaRecon DL, an AI-based technology to enhance CBCT imaging quality. Clearance is pending; the technology will be showcased at RSNA 2024.

Why It Matters - GE HealthCare's 510(k) submission for AI-enhanced imaging technology could lead to a competitive edge in the medical imaging market, impacting future revenue and stock performance.

...

GEHC Frequently asked questions

The highest forecasted price for GEHC is $110 from David Toung at Argus Research.

The lowest forecasted price for GEHC is $74 from Patrick Wood from Morgan Stanley

The GEHC analyst ratings consensus are 13 buy ratings, 6 hold ratings, and 1 sell ratings.